{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CB1", "L-theanine", "anxiety", "endocannabinoid system", "excitotoxicity", "flumazenil", "mood disorders", "neuroprotection"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32560413", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "17"}], "Language": ["eng"], "ELocationID": ["1803", "10.3390/nu12061803"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "12", "Issue": "6", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "17"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Novel Therapeutic Approach for the Management of Mood Disorders: In Vivo and In Vitro Effect of a Combination of L-Theanine, <i>Melissa</i> <i>officinalis</i> L. and <i>Magnolia officinalis</i> Rehder & E.H. Wilson.", "Abstract": {"AbstractText": ["Mood disorders represent one of the most prevalent and costly psychiatric diseases worldwide. The current therapies are generally characterized by several well-known side effects which limit their prolonged use. The use of herbal medicine for the management of several psychiatric conditions is becoming more established, as it is considered a safer support to conventional pharmacotherapy. The aim of this study was to investigate the possible anxiolytic and antidepressant activity of a fixed combination of L-theanine, <i>Magnolia officinalis</i>, and <i>Melissa officinalis</i> (TMM) in an attempt to evaluate how the multiple modulations of different physiological systems may contribute to reducing mood disorders. TMM showed an anxiolytic-like and antidepressant-like activity in vivo, which was related to a neuroprotective effect in an in vitro model of excitotoxicity. The effect of TMM was not altered by the presence of flumazenil, thus suggesting a non-benzodiazepine-like mechanism of action. On the contrary, a significant reduction in the effect was observed in animals and neuronal cells co-treated with AM251, a cannabinoid receptor type 1 (CB1) antagonist, suggesting that the endocannabinoid system may be involved in the TMM mechanism of action. In conclusion, TMM may represent a useful and safe candidate for the management of mood disorders with an innovative mechanism of action, particularly as an adjuvant to conventional therapies."]}, "AuthorList": [{"Identifier": ["0000-0002-2203-5285"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology, University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy."}], "LastName": "Borgonetti", "ForeName": "Vittoria", "Initials": "V"}, {"Identifier": ["0000-0002-5976-780X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Chemistry and Pharmacy-Department of Excellence 2018-2022, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy."}], "LastName": "Governa", "ForeName": "Paolo", "Initials": "P"}, {"Identifier": ["0000-0003-2997-4178"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Sciences, Earth and Environment, University of Siena, Strada Laterina 8, 53100 Siena, Italy."}], "LastName": "Biagi", "ForeName": "Marco", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology, University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy."}], "LastName": "Galeotti", "ForeName": "Nicoletta", "Initials": "N"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Glutamates"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "8021PR16QO", "NameOfSubstance": "theanine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Glutamates"}, {"QualifierName": [], "DescriptorName": "Magnolia"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Melissa"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Mood Disorders"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nemeroff C.B., Owens M.J. Treatment of mood disorders. Nat. Neurosci. 2002;5:1068\u20131070. doi: 10.1038/nn943.", "ArticleIdList": ["10.1038/nn943", "12403988"]}, {"Citation": "Kimball S.M., Mirhosseini N., Rucklidge J. Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention. Nutrients. 2018;10:152. doi: 10.3390/nu10020152.", "ArticleIdList": ["10.3390/nu10020152", "PMC5852728", "29385721"]}, {"Citation": "Yeung K.S., Hernandez M., Mao J.J., Haviland I., Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phyther. Res. 2018;32:865\u2013891. doi: 10.1002/ptr.6033.", "ArticleIdList": ["10.1002/ptr.6033", "PMC5938102", "29464801"]}, {"Citation": "Tiller J.W.G. Depression and anxiety. Med. J. Aust. 2013;199:S28\u2013S31. doi: 10.5694/mja12.10628.", "ArticleIdList": ["10.5694/mja12.10628", "25370281"]}, {"Citation": "Sarris J., Byrne G.J., Cribb L., Oliver G., Murphy J., Macdonald P., Nazareth S., Karamacoska D., Galea S., Short A., et al. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. J. Psychiatr. Res. 2019;110:31\u201337. doi: 10.1016/j.jpsychires.2018.12.014.", "ArticleIdList": ["10.1016/j.jpsychires.2018.12.014", "30580081"]}, {"Citation": "World Health Organization.  [(accessed on 16 June 2020)]; Available online:  https://www.who.int."}, {"Citation": "European Medicine Agency.  [(accessed on 16 June 2020)]; Available online:  https://www.ema.europa.eu."}, {"Citation": "Yang C.S., Chen G., Wu Q. Recent scientific studies of a traditional Chinese medicine, tea, on prevention of chronic diseases. J. Tradit. Complement. Med. 2014;4:17\u201323. doi: 10.4103/2225-4110.124326.", "ArticleIdList": ["10.4103/2225-4110.124326", "PMC4032838", "24872929"]}, {"Citation": "Williams J.L., Everett J.M., D\u2019Cunha N.M., Sergi D., Georgousopoulou E.N., Keegan R.J., McKune A.J., Mellor D.D., Anstice N., Naumovski N. The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: A Systematic Review. Plant Foods Hum. Nutr. 2019 doi: 10.1007/s11130-019-00771-5.", "ArticleIdList": ["10.1007/s11130-019-00771-5", "31758301"]}, {"Citation": "Zukhurova M., Prosvirnina M., Daineko A., Simanenkova A., Petrishchev N., Sonin D., Galagudza M., Shamtsyan M., Juneja L.R., Vlasov T. L-theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated injury in the rat model of cerebral ischemia-reperfusion. Phyther. Res. 2013;27:1282\u20131287. doi: 10.1002/ptr.4868.", "ArticleIdList": ["10.1002/ptr.4868", "23097345"]}, {"Citation": "Kakuda T., Hinoi E., Abe A., Nozawa A., Ogura M., Yoneda Y. Theanine, an ingredient of green tea, inhibits [3H] glutamine transport in neurons and astroglia in rat brain. J. Neurosci. Res. 2008;86:1846\u20131856. doi: 10.1002/jnr.21637.", "ArticleIdList": ["10.1002/jnr.21637", "18293419"]}, {"Citation": "Bergink V., van Megen H.J.G.M., Westenberg H.G.M. Glutamate and anxiety. Eur. Neuropsychopharmacol. 2004;14:175\u2013183. doi: 10.1016/S0924-977X(03)00100-7.", "ArticleIdList": ["10.1016/S0924-977X(03)00100-7", "15056476"]}, {"Citation": "Borgonetti V., Governa P., Montopoli M., Biagi M. Cannabis sativa L. Constituents and Their Role in Neuroinflammation. Curr. Bioact. Compd. 2019;15:147\u2013158. doi: 10.2174/1573407214666180703130525.", "ArticleIdList": ["10.2174/1573407214666180703130525"]}, {"Citation": "S\u00e1nchez-Bl\u00e1zquez P., Rodr\u00edguez-Mu\u00f1oz M., Garz\u00f3n J. The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: Implications in psychosis and schizophrenia. Front. Pharmacol. 2014;4:169. doi: 10.3389/fphar.2013.00169.", "ArticleIdList": ["10.3389/fphar.2013.00169", "PMC3877778", "24427139"]}, {"Citation": "Chiarlone A., Bellocchio L., Bl\u00e1zquez C., Resel E., Soria-G\u00f3mez E., Cannich A., Ferrero J.J., Sagredo O., Benito C., Romero J., et al. A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc. Natl. Acad. Sci. USA. 2014;111:8257\u20138262. doi: 10.1073/pnas.1400988111.", "ArticleIdList": ["10.1073/pnas.1400988111", "PMC4050577", "24843137"]}, {"Citation": "Maruyama Y., Kuribara H., Morita M., Yuzurihara M., Weintraub S.T. Identification of magnolol and honokiol as anxiolytic agents in extracts of Saiboku-to, an oriental herbal medicine. J. Nat. Prod. 1998;61:135\u2013138. doi: 10.1021/np9702446.", "ArticleIdList": ["10.1021/np9702446", "9461663"]}, {"Citation": "World Health Organization . WHO Monographs on Selected Medicinal Plants Volume 4. World Health Organization; Geneva, Switzerland: 2009."}, {"Citation": "Rempel V., Fuchs A., Hinz S., Karcz T., Lehr M., Koetter U., M\u00fcller C.E. Magnolia extract, magnolol, and metabolites: Activation of cannabinoid CB2 receptors and blockade of the related GPR. ACS Med. Chem. Lett. 2013;4:41\u201345. doi: 10.1021/ml300235q.", "ArticleIdList": ["10.1021/ml300235q", "PMC4027495", "24900561"]}, {"Citation": "Kalueff A.V., Nutt D.J. Role of GABA in anxiety and depression. Depress. Anxiety. 2007;24:495\u2013517. doi: 10.1002/da.20262.", "ArticleIdList": ["10.1002/da.20262", "17117412"]}, {"Citation": "EMA Assessment Report on Melissa officinalis L., Folium.  [(accessed on 16 June 2020)]; Available online:  https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-melissa-officinalis-l-folium_en.pdf."}, {"Citation": "Shakeri A., Sahebkar A., Javadi B. Melissa officinalis L.\u2014A review of its traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 2016;188:204\u2013228. doi: 10.1016/j.jep.2016.05.010.", "ArticleIdList": ["10.1016/j.jep.2016.05.010", "27167460"]}, {"Citation": "Sasaki K., El Omri A., Kondo S., Han J., Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav. Brain Res. 2013;238:86\u201394. doi: 10.1016/j.bbr.2012.10.010.", "ArticleIdList": ["10.1016/j.bbr.2012.10.010", "23085339"]}, {"Citation": "Awad R., Muhammad A., Durst T., Trudeau V.L., Arnason J.T. Bioassay-guided Fractionation of Lemon Balm (Melissa officinalis L.) using an In Vitro Measure of GABA Transaminase Activity. Phyther. Res. 2009;23:1075\u20131081. doi: 10.1002/ptr.2712.", "ArticleIdList": ["10.1002/ptr.2712", "19165747"]}, {"Citation": "McGrath J.C., Lilley E. Implementing guidelines on reporting research using animals (ARRIVE etc.): New requirements for publication in BJP. Br. J. Pharmacol. 2015;172:3189\u20133193. doi: 10.1111/bph.12955.", "ArticleIdList": ["10.1111/bph.12955", "PMC4500358", "25964986"]}, {"Citation": "Charan J., Kantharia N. How to calculate sample size in animal studies? J. Pharmacol. Pharmacother. 2013;4:303\u2013306. doi: 10.4103/0976-500X.119726.", "ArticleIdList": ["10.4103/0976-500X.119726", "PMC3826013", "24250214"]}, {"Citation": "Sanna M.D., Borgonetti V., Galeotti N. \u03bc Opioid Receptor-Triggered Notch-1 Activation Contributes to Morphine Tolerance: Role of Neuron\u2014Glia Communication. Mol. Neurobiol. 2019 doi: 10.1007/s12035-019-01706-6.", "ArticleIdList": ["10.1007/s12035-019-01706-6", "31347026"]}, {"Citation": "Bourin M., Hascoet M. The mouse light/dark box test. Eur. J. Pharmacol. 2003;463:55\u201365. doi: 10.1016/S0014-2999(03)01274-3.", "ArticleIdList": ["10.1016/S0014-2999(03)01274-3", "12600702"]}, {"Citation": "Yalcin I., Bohren Y., Waltisperger E., Sage-Ciocca D., Yin J.C., Freund-Mercier M.J., Barrot M. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol. Psychiatry. 2011;70:946\u2013953. doi: 10.1016/j.biopsych.2011.07.017.", "ArticleIdList": ["10.1016/j.biopsych.2011.07.017", "21890110"]}, {"Citation": "Bodnoff S.R., Suranyi-Cadotte B., Aitken D.H., Quirion R., Meaney M.J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology. 1988;95:298\u2013302. doi: 10.1007/BF00181937.", "ArticleIdList": ["10.1007/BF00181937", "3137614"]}, {"Citation": "Galeotti N., Ghelardini C. Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation. Int. J. Neuropsychopharmacol. 2012;15:781\u2013793. doi: 10.1017/S1461145711000897.", "ArticleIdList": ["10.1017/S1461145711000897", "21682943"]}, {"Citation": "Kritis A.A., Stamoula E.G., Paniskaki K.A., Vavilis T.D. Researching glutamate\u2014Induced cytotoxicity in different cell lines: A comparative/collective analysis/study. Front. Cell. Neurosci. 2015;9:91. doi: 10.3389/fncel.2015.00091.", "ArticleIdList": ["10.3389/fncel.2015.00091", "PMC4362409", "25852482"]}, {"Citation": "Curtis M.J., Alexander S., Cirino G., Docherty J.R., George C.H., Giembycz M.A., Hoyer D., Insel P.A., Izzo A.A., Ji Y., et al. Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers. Br. J. Pharmacol. 2018;175:987\u2013993. doi: 10.1111/bph.14153.", "ArticleIdList": ["10.1111/bph.14153", "PMC5843711", "29520785"]}, {"Citation": "Sanna M.D., Les F., Lopez V., Galeotti N. Lavender (Lavandula angustifolia Mill.) essential oil alleviates neuropathic pain in mice with spared nerve injury. Front. Pharmacol. 2019;10:472. doi: 10.3389/fphar.2019.00472.", "ArticleIdList": ["10.3389/fphar.2019.00472", "PMC6521744", "31143116"]}, {"Citation": "Barfield E.T., Alexandra Moser V., Hand A., Grisel J.E. \u00df-Endorphin Modulates the Effect of Stress on Novelty-Suppressed Feeding. Front. Behav. Neurosci. 2013;7:19. doi: 10.3389/fnbeh.2013.00019.", "ArticleIdList": ["10.3389/fnbeh.2013.00019", "PMC3596765", "23503677"]}, {"Citation": "Pereira V., Goudet C. Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors. Front. Mol. Neurosci. 2019;11:464. doi: 10.3389/fnmol.2018.00464.", "ArticleIdList": ["10.3389/fnmol.2018.00464", "PMC6328474", "30662395"]}, {"Citation": "Jin Y., Sun L.H., Yang W., Cui R.J., Xu S.B. The role of BDNF in the neuroimmune axis regulation of mood disorders. Front. Neurol. 2019;10:515. doi: 10.3389/fneur.2019.00515.", "ArticleIdList": ["10.3389/fneur.2019.00515", "PMC6559010", "31231295"]}, {"Citation": "Bandelow B., Michaelis S., Wedekind D. Treatment of anxiety disorders. Dialogues Clin. Neurosci. 2017;19:93\u2013107.", "ArticleIdList": ["PMC5573566", "28867934"]}, {"Citation": "Governa P., Carullo G., Biagi M., Aiello F. Evaluation of the In Vitro Wound-Healing Activity of Calabrian Honeys. Antioxidants. 2019;8:36. doi: 10.3390/antiox8020036.", "ArticleIdList": ["10.3390/antiox8020036", "PMC6406906", "30736314"]}, {"Citation": "Chiocchio I., Poli F., Governa P., Biagi M., Lianza M. Wound healing and in vitro antiradical activity of five Sedum species grown within two sites of community importance in Emilia-Romagna (Italy) Plant Biosyst. 2019;153:610\u2013615. doi: 10.1080/11263504.2018.1549611.", "ArticleIdList": ["10.1080/11263504.2018.1549611"]}, {"Citation": "Panossian A., Wikman G., Sarris J. Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17:481\u2013493. doi: 10.1016/j.phymed.2010.02.002.", "ArticleIdList": ["10.1016/j.phymed.2010.02.002", "20378318"]}, {"Citation": "Galeotti N., Vivoli E., Bilia A.R., Vincieri F.F., Ghelardini C. St. John\u2019s Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity. Biochem. Pharmacol. 2010;79:1327\u20131336. doi: 10.1016/j.bcp.2009.12.016.", "ArticleIdList": ["10.1016/j.bcp.2009.12.016", "20045676"]}, {"Citation": "Winer E.S., Bryant J., Bartoszek G., Rojas E., Nadorff M.R., Kilgore J. Mapping the relationship between anxiety, anhedonia, and depression. J. Affect. Disord. 2017;221:289\u2013296. doi: 10.1016/j.jad.2017.06.006.", "ArticleIdList": ["10.1016/j.jad.2017.06.006", "PMC6080718", "28668590"]}, {"Citation": "Baumeister H., Hutter N., Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst. Rev. 2012;12:CD008381. doi: 10.1002/14651858.CD008381.pub2.", "ArticleIdList": ["10.1002/14651858.CD008381.pub2", "23235661"]}, {"Citation": "Salum G.A., Manfro G.G., Fleck M.P. What is not \u201cEffective\u201d in Mild to Moderate Depression: Antidepressants or the Hamilton Rating Scale for Depression? CNS Spectr. 2011;16:99. doi: 10.1017/S1092852912000259.", "ArticleIdList": ["10.1017/S1092852912000259", "24725372"]}, {"Citation": "Ferguson J.M. The effects of antidepressants on sexual functioning in depressed patients: A review. J. Clin. Psychiatry. 2001;62(Suppl. S3):22\u201334.", "ArticleIdList": ["11229450"]}, {"Citation": "Hidese S., Ota M., Wakabayashi C., Noda T., Ozawa H., Okubo T., Kunugi I. Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study. Acta Neuropsychiatr. 2017;29:72\u201379. doi: 10.1017/neu.2016.33.", "ArticleIdList": ["10.1017/neu.2016.33", "27396868"]}, {"Citation": "Wakabayashi C., Numakawa T., Ninomiya M., Chiba S., Kunugi H. Behavioral and molecular evidence for psychotropic effects in L-theanine. Psychopharmacology. 2012;219:1099\u20131109. doi: 10.1007/s00213-011-2440-z.", "ArticleIdList": ["10.1007/s00213-011-2440-z", "21861094"]}, {"Citation": "Yin C., Gou L., Liu Y., Yin X., Zhang L., Jia G., Zhuang X. Antidepressant-like effects of L-theanine in the forced swim and tail suspension tests in mice. Phytother. Res. 2011;25:1636\u20131639. doi: 10.1002/ptr.3456.", "ArticleIdList": ["10.1002/ptr.3456", "21425373"]}, {"Citation": "Petrovic M., Mariman A., Warie H., Afschrift M., Pevernagie D. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin. Belg. 2003;58:27\u201336. doi: 10.1179/acb.2003.58.1.004.", "ArticleIdList": ["10.1179/acb.2003.58.1.004", "12723259"]}, {"Citation": "Hidese S., Ogawa S., Ota M., Ishida I., Yasukawa Z., Ozeki M., Kunugi H. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019;11:2362. doi: 10.3390/nu11102362.", "ArticleIdList": ["10.3390/nu11102362", "PMC6836118", "31623400"]}, {"Citation": "White D.J., de Klerk S., Woods W., Gondalia S., Noonan C., Scholey A.B. Anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: A randomised, double-blind, placebo-controlled, crossover trial. Nutrients. 2016;8:53. doi: 10.3390/nu8010053.", "ArticleIdList": ["10.3390/nu8010053", "PMC4728665", "26797633"]}, {"Citation": "Lu K., Gray M.A., Oliver C., Liley D.T., Harrison B.J., Bartholomeusz C.F., Phan K.L., Nathan P.J. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum. Psychopharmacol. 2004;19:457\u2013465. doi: 10.1002/hup.611.", "ArticleIdList": ["10.1002/hup.611", "15378679"]}, {"Citation": "Lopes Sakamoto F., Metzker Pereira Ribeiro R., Amador Bueno A., Oliveira Santos H. Psychotropic effects of L-theanine and its clinical properties: From the management of anxiety and stress to a potential use in schizophrenia. Pharmacol. Res. 2019;147:104395. doi: 10.1016/j.phrs.2019.104395.", "ArticleIdList": ["10.1016/j.phrs.2019.104395", "31412272"]}, {"Citation": "Kakuda T., Yanase H., Utsunomiya K., Nozawa A., Unno T., Kataoka K. Protective effect of \u03b3-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils. Neurosci. Lett. 2000;289:189\u2013192. doi: 10.1016/S0304-3940(00)01286-6.", "ArticleIdList": ["10.1016/S0304-3940(00)01286-6", "10961661"]}, {"Citation": "Ota M., Wakabayashi C., Sato N., Hori H., Hattori K., Teraishi T., Ozakawa H., Okubo T., Kunugi H. Effect of L-theanine on glutamatergic function in patients with schizophrenia. Acta Neuropsychiatr. 2015;27:291\u2013296. doi: 10.1017/neu.2015.22.", "ArticleIdList": ["10.1017/neu.2015.22", "25896423"]}, {"Citation": "Ogawa S., Ota M., Ogura J., kato K., Konugi H. Effects of L-theanine on anxiety-like behavior, cerebrospinal fluid amino acid profile, and hippocampal activity in Wistar Kyoto rats. Psychopharmacology. 2018;235:37\u201345. doi: 10.1007/s00213-017-4743-1.", "ArticleIdList": ["10.1007/s00213-017-4743-1", "28971241"]}, {"Citation": "Poleszak E., Soca\u0142a K., Szopa A., Wr\u00f3bel A., Szewczyk B., Kasperek R., Blicharska E., Nowak G., Wla\u017a P. Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in mice. J. Neural Transm. 2011;118:857\u2013864. doi: 10.1007/s00702-011-0585-x.", "ArticleIdList": ["10.1007/s00702-011-0585-x", "PMC3104009", "21298298"]}, {"Citation": "Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62:63\u201377. doi: 10.1016/j.neuropharm.2011.07.036.", "ArticleIdList": ["10.1016/j.neuropharm.2011.07.036", "PMC3205453", "21827775"]}, {"Citation": "Ibarra A., Feuillere N., Roller M., Lesburgere E., Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010;17:397\u2013403. doi: 10.1016/j.phymed.2010.01.012.", "ArticleIdList": ["10.1016/j.phymed.2010.01.012", "20171069"]}, {"Citation": "Ghazizadeh J., Hamedeyazdan S., Torbati M., Farajdokht F., Fakhari A., Mahmoudi J., Araj-khodaei M., Sadigh-Eteghad S. Melissa officinalis L. hydro-alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis. Exp. Physiol. 2020;105:707\u2013720. doi: 10.1113/EP088254.", "ArticleIdList": ["10.1113/EP088254", "32003913"]}, {"Citation": "Haybar H., Javid A.Z., Haghighizadeh M.H., Valizadeh E., Mohaghegh S.M., Mohammadzadeh A. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin. Nutr. ESPEN. 2018;26:47\u201352. doi: 10.1016/j.clnesp.2018.04.015.", "ArticleIdList": ["10.1016/j.clnesp.2018.04.015", "29908682"]}, {"Citation": "Rey A.A., Purrio M., Viveros M.P., Lutz B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of gabaergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012;37:2624\u20132634. doi: 10.1038/npp.2012.123.", "ArticleIdList": ["10.1038/npp.2012.123", "PMC3473327", "22850737"]}, {"Citation": "Talbott S.M., Talbott J.A., Pugh M. Effect of Magnolia officinalis and Phellodendron amurense (Relora\u00ae) on cortisol and psychological mood state in moderately stressed subjects. J. Int. Soc. Sports Nutr. 2013;10:37. doi: 10.1186/1550-2783-10-37.", "ArticleIdList": ["10.1186/1550-2783-10-37", "PMC3750820", "23924268"]}, {"Citation": "Kuribara H., Stavinoha W.B., Maruyama Y. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J. Pharm. Pharmacol. 1998;50:819\u2013826. doi: 10.1111/j.2042-7158.1998.tb07146.x.", "ArticleIdList": ["10.1111/j.2042-7158.1998.tb07146.x", "9720634"]}, {"Citation": "Niciu M.J., Kelmendi B., Sanacora G. Overview of Glutamatergic Neurotransmission in the Nervous System. Pharmacol. Biochem. Behav. 2012;100:656\u2013664. doi: 10.1016/j.pbb.2011.08.008.", "ArticleIdList": ["10.1016/j.pbb.2011.08.008", "PMC3253893", "21889952"]}, {"Citation": "Cortese B.M., Phan K.L. The role of glutamate in anxiety and related disorders. CNS Spectr. 2005;10:820\u2013830. doi: 10.1017/S1092852900010427.", "ArticleIdList": ["10.1017/S1092852900010427", "16400245"]}, {"Citation": "Croce N., Math\u00e9 A.A., Gelfo F., Caltagirone C., Bernardini S., Angelucci F. Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration. J. Psychopharmacol. 2014;28:964\u2013972. doi: 10.1177/0269881114529379.", "ArticleIdList": ["10.1177/0269881114529379", "24699060"]}, {"Citation": "Mancini A., Chelini A., Di Capua A., Castelli L., Brogi S., Paolino M., Giuliani G., Cappelli A., Frosini M., Ricci L., et al. Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents. Eur. J. Med. Chem. 2017;126:614\u2013630. doi: 10.1016/j.ejmech.2016.11.053.", "ArticleIdList": ["10.1016/j.ejmech.2016.11.053", "27923201"]}, {"Citation": "Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D.M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: Involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 2002;80:589\u2013597. doi: 10.1046/j.0022-3042.2001.00728.x.", "ArticleIdList": ["10.1046/j.0022-3042.2001.00728.x", "11841566"]}, {"Citation": "Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007;10:1089\u20131093. doi: 10.1038/nn1971.", "ArticleIdList": ["10.1038/nn1971", "17726474"]}, {"Citation": "Zhong F., Liu L., Wei J.L., Hu Z.L., Li L., Wang S., Xu J.M., Zhou X.F., Li C.Q., Yang Z.Y., et al. Brain-derived neurotrophic factor precursor in the hippocampus regulates both depressive and anxiety-like behaviors in rats. Front. Psychiatry. 2019;9:776. doi: 10.3389/fpsyt.2018.00776.", "ArticleIdList": ["10.3389/fpsyt.2018.00776", "PMC6355684", "30740068"]}, {"Citation": "Phillips C. Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection. Neural Plast. 2017;2017:7260130. doi: 10.1155/2017/7260130.", "ArticleIdList": ["10.1155/2017/7260130", "PMC5591905", "28928987"]}, {"Citation": "Finsterwald C., Fiumelli H., Cardinaux J.R., Martin J.L. Regulation of dendritic development by BDNF requires activation of CRTC1 by glutamate. J. Biol. Chem. 2010;285:28587\u201328595. doi: 10.1074/jbc.M110.125740.", "ArticleIdList": ["10.1074/jbc.M110.125740", "PMC2937884", "20639200"]}, {"Citation": "Martin J.L., Finsterwald C. Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development. Commun. Integr. Biol. 2011;4:14\u201316. doi: 10.4161/cib.13761.", "ArticleIdList": ["10.4161/cib.13761", "PMC3073261", "21509169"]}, {"Citation": "Mattson M.P. Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders. NeuroMolecular Med. 2003;3:65\u201394. doi: 10.1385/NMM:3:2:65.", "ArticleIdList": ["10.1385/NMM:3:2:65", "12728191"]}, {"Citation": "Mattson M.P. Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease. Ann. N. Y. Acad. Sci. 2009;1144:97\u2013112. doi: 10.1196/annals.1418.005.", "ArticleIdList": ["10.1196/annals.1418.005", "PMC2614307", "19076369"]}, {"Citation": "De la Iglesia-Larrad J.I., Barral C., Casado-Espada N.M., de Alarc\u00f3n R., Maci\u00e1-Casas A., Vicente Hernandez B., Roncero C. Benzodiazepine abuse, misuse, dependence, and withdrawal among schizophrenic patients: A review of the literature. Psychiatry Res. 2020;284:112660. doi: 10.1016/j.psychres.2019.112660.", "ArticleIdList": ["10.1016/j.psychres.2019.112660", "31757643"]}, {"Citation": "Lader M., Kyriacou A. Withdrawing Benzodiazepines in Patients With Anxiety Disorders. Curr. Psychiatry Rep. 2016;18:8. doi: 10.1007/s11920-015-0642-5.", "ArticleIdList": ["10.1007/s11920-015-0642-5", "26733324"]}, {"Citation": "Baur R., Gertsch J., Sigel E. The cannabinoid CB 1receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA A receptors. Br. J. Pharmacol. 2012;165:2479\u20132484. doi: 10.1111/j.1476-5381.2011.01405.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01405.x", "PMC3423234", "21470203"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "14"}, {"Year": "2020", "Month": "5", "Day": "19"}, {"Year": "2020", "Month": "6", "Day": "16"}, {"Year": "2020", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32560413", "PMC7353338", "10.3390/nu12061803", "nu12061803"]}}], "PubmedBookArticle": []}